GLP-1 Therapy for Global Obesity Management
Global analysis shows over 27% of adults eligible for GLP-1 obesity therapy, mostly in low-income regions, highlighting access inequities and need for equitable deployment strategies.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.